How Uveal Melanoma Differs from Cutaneous Melanoma

Author(s):

Sunandana Chandra, MD, MS, explains how uveal melanoma is different from cutaneous melanoma, including prevalence, molecular mutations, and survival prognosis after metastasis.

Now Viewing

EP: 1.How Uveal Melanoma Differs from Cutaneous Melanoma

EP: 2.Common Symptoms of Uveal Melanoma and the Typical Diagnostic Journey of the Patient

EP: 3.Historic and Current Treatment Options for mUM

EP: 4.Implications of Clinical Trial Data on Bispecific T-Cell Receptor Immunotherapy for mUM

EP: 5.Patient Eligibility and Logistical and Safety Considerations for Tebentafusp Treatment in mUM

EP: 6.An Expert’s Experience in Prescribing Tebentafusp and Other Therapies for mUM and a Commentary on Patient Education and Resources

EP: 7.Treatment Options for Patients with mUM Who Are Ineligible for Bispecific T-Cell Receptor Immunotherapy

EP: 8.Advice for Patients Living with Metastatic Uveal Melanoma

Stay up to date on cancer updates, research and education

Subscribe Now!